2022
DOI: 10.1002/term.3327
|View full text |Cite
|
Sign up to set email alerts
|

Human cardiac organoids to model COVID‐19 cytokine storm induced cardiac injuries

Abstract: Acute cardiac injuries occur in 20%–25% of hospitalized COVID‐19 patients. Herein, we demonstrate that human cardiac organoids (hCOs) are a viable platform to model the cardiac injuries caused by COVID‐19 hyperinflammation. As IL‐1β is an upstream cytokine and a core COVID‐19 signature cytokine, it was used to stimulate hCOs to induce the release of a milieu of proinflammatory cytokines that mirror the profile of COVID‐19 cytokine storm. The IL‐1β treated hCOs recapitulated transcriptomic, structural, and func… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(5 citation statements)
references
References 81 publications
(97 reference statements)
0
5
0
Order By: Relevance
“…Follow-up studies showed that this model was transcriptomically similar to adult myocardium ( Kerr et al, 2021 ) and that its vascularization could be increased by the upregulation of the hypoxia-inducible factor HIF-α ( Coyle et al, 2021 ). Furthermore, these microtissues were used to model cardiac injuries caused by COVID-19 hyperinflammation through stimulation with IL-1β to mimic a cytokine storm ( Arhontoulis et al, 2022 ).…”
Section: Cardiac Microtissuesmentioning
confidence: 99%
“…Follow-up studies showed that this model was transcriptomically similar to adult myocardium ( Kerr et al, 2021 ) and that its vascularization could be increased by the upregulation of the hypoxia-inducible factor HIF-α ( Coyle et al, 2021 ). Furthermore, these microtissues were used to model cardiac injuries caused by COVID-19 hyperinflammation through stimulation with IL-1β to mimic a cytokine storm ( Arhontoulis et al, 2022 ).…”
Section: Cardiac Microtissuesmentioning
confidence: 99%
“…Organoids, due to their ability to closely mimic the cellular composition and internal architecture of native organs and their ability to be derived from patient-specific cells, offer the promise to overcome the major limitations in using animal and 2D cell culture models as mentioned above to investigate viral infection in human. Using respective organoid models, studies have demonstrated that COVID-19 affects not only the lung 43,44 but also the heart, 45,46 gastrointestinal tract, 47 blood vessels, and kidney. 48 These echo the multi-organ dysfunction observed in human patients infected by severe acute respiratory syndrome coronavirus 2.…”
Section: Challenges and Future Directionsmentioning
confidence: 99%
“…111,112 Human cardiac organoids and vascular organoids have been established to explore SARS-CoV-2 infectivity in the cardiovascular system. 42,113,114 Mils et al demonstrated that infected cardiac organoids could recapitulate key clinical features of diastolic malfunction in COVID-19 patients. 115 The study also showed that cytokine-induced cardiac dysfunction in cardiac organoids could be attenuated by using bromodomain and extraterminal family inhibitors (BETi).…”
Section: Other Organoidsmentioning
confidence: 99%
“…SARS‐CoV‐2 infection can cause cardiac injury and dysfunction in patients and increase the risk of mortality 111,112 . Human cardiac organoids and vascular organoids have been established to explore SARS‐CoV‐2 infectivity in the cardiovascular system 42,113,114 . Mils et al demonstrated that infected cardiac organoids could recapitulate key clinical features of diastolic malfunction in COVID‐19 patients 115 .…”
Section: Human Organoids For Studying Sars‐cov‐2 Infectivitymentioning
confidence: 99%